|
2024
|
Invention
|
Use, as anticancer agent, of next generation parp inhibitor for treating cancer having atm and as... |
|
2023
|
Invention
|
Method for preparing intermediate of phthalazinone derivative. The present invention relates to a... |
|
|
Invention
|
Pharmaceutical composition including phthalazinone derivative for co-administration with anticanc... |
|
2022
|
Invention
|
Methods of treating disorders with phthalazinone derivatives.
The present invention relates to m... |
|
|
Invention
|
Methods of treating disorders with phthalazinone derivatives. The present invention relates to me... |
|
|
Invention
|
Crystalline forms of phthalazinone compound. The present specification provides crystalline forms... |
|
|
Invention
|
Anticancer drug use of phthalazinone derivative as cancer treatment agent for patients with resis... |
|
2020
|
Invention
|
A pharmaceutical composition comprising phthalazinone derivatives. The present invention relates ... |
|
|
Invention
|
Pharmaceutical composition comprising phthalazinone derivatives. The present invention relates to... |
|
|
Invention
|
Process for preparing a phthalazinone derivative and intermediates thereof. HH)-one, or a pharmac... |
|
|
Invention
|
Crystalline forms of phthacaz1nonf compound. 2H2H)-one hydrochloride, methods of preparing the sa... |
|
|
Invention
|
Process for preparing a phthalazinone derivative and intermediates thereof. The present applicati... |
|
2017
|
Invention
|
Phtalazinone derivatives and manufacturing process thereof. The present invention relates to phth... |
|
2016
|
Invention
|
Phthalazinone derivatives and manufacturing process thereof. The present invention relates to pht... |
